ÂÜÀòÂÒÂ×

Judith Klimovsky, MD, currently serves as the Executive Vice President & Chief Development Officer of Genmab, an international biotechnology company developing antibody therapeutics for cancer, where she leads the company’s product development efforts. She has more than 15 years of experience in product strategy, drug development, and medical affairs for the biotech and pharmaceutical industry. Prior to joining Genmab, she held successively senior positions at Novartis, Bristol-Myers Squibb, and Merck, and led or contributed to the clinical development of key cancer drugs, including Ixempra, Mektovi, Braftovi, and Afinitor. Previously, Dr Klimovsky served in various hematology clinical practice positions in Buenos Aires, Argentina. Dr Klimovsky earned her MD from the Buenos Aires University School of Medicine.